Pioneer Management Consulting launches biotech venture firm to fund brain cancer research
Pioneer Management Consulting has launched an investment effort aimed at pursuing treatments for a rare and lethal pediatric brain cancer — an illness that has struck the family of one of the firm's co-owners. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 14, 2023 Category: Biotechnology Authors: Alyxandra Sego Source Type: news
Science ’s 2023 Breakthrough of the Year: Weight loss drugs with a real shot at fighting obesity
Show / hide sections navigation
2023 Breakthrough of the Year
Runners-up
Breakdowns
Video
Obesity plays out as a private struggle and a public health crisis. In the United States, about 70% of adults are affected by excess weight, and in Europe that number is more than half. The stigma against fat can be crushing; its risks, life-threatening. Defined as a body mass index of at least 30, obesity is thought to power type 2 diabetes, heart disease, arthritis, fatty liver disease, and certain cancers.
Yet drug treatments...
Source: ScienceNOW - December 14, 2023 Category: Science Source Type: news
Are you a smoker? Read this before having your next cigarette
We all know how cigarettes are bad for us and how smoking them can damage our heart and lungs, and even result in cancer. But did you know it affects your brain too? (Source: The Economic Times)
Source: The Economic Times - December 13, 2023 Category: Consumer Health News Source Type: news
IBA to install cyclotron in Poland
Proton therapy developer Ion Beam Application (IBA) will install a Cyclone 30XP in Poland for the production of astatine-211 (At-211) for oncology applications. At-211 is an alpha particle emitter used in oncology for targeted therapies to treat brain, thyroid, ovarian, breast, and prostate cancer. This is the company’s third installation in Europe for A-211 production, following earlier installations in Germany and France. Beyond At-211, the company is also developing accelerator applications for other theranostic isotopes, IBA said. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 13, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
GT Medical Technologies inks supply deal with Perspective Therapeutics
GT Medical Technologies has inked an agreement with Perspective Therapeutics to acquire all radioactive cesium-131 seed assets from its subsidiary Isoray Medical.
The company hopes the deal will decrease customer order lead times for the cesium-131 seeds – which are a key component to its GammaTile therapy for patients with operable brain tumors – "allowing even more patients to benefit from this … technology," it said. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 12, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Subspecialties Nuclear Radiology Source Type: news
David Robb, Veteran Labor Reporter at Hollywood Trades, Dies at 74
David Robb, a veteran labor reporter whose tenure included stints at Variety, The Hollywood Reporter and Deadline, died Friday at his home in Los Angeles, Deadline reported. Robb suffered a stroke and was diagnosed with inoperable cancer of the brain stem and entered hospice care in late November,…#davidrobb #variety #hollywoodreporter #deadline #laweekly #robb #communityparty #michaelwilson #lawrenceofarabia #hollywood (Source: Reuters: Health)
Source: Reuters: Health - December 9, 2023 Category: Consumer Health News Source Type: news
Dave Robb, Veteran Hollywood Labor Reporter, Dies at 74
Dave Robb, who spent more than four decades on the Hollywood labor beat for The Hollywood Reporter, Variety and, most recently, Deadline, has died. He was 74. Robb died peacefully Friday night at his Los Angeles home after being diagnosed in late October with inoperable cancer of the brain stem,…#daverobb #hollywood #hollywoodreporter #variety #deadline #thr #penskemediagroup #wga #sagaftra #robertjdowling (Source: Reuters: Health)
Source: Reuters: Health - December 9, 2023 Category: Consumer Health News Source Type: news
Dave Robb, Veteran Hollywood Labor Reporter and Variety Alum, Dies at 74
Dave Robb, a longtime Hollywood labor reporter who worked for Variety in the 1980s and ’90s, died Dec. 8 at his home in Los Angeles. He was 74 and had recently been diagnosed with cancer of the brain stem. Robb most recently worked for Deadline, Variety‘s sibling company under the Penske Media…#daverobb #hollywood #variety #deadline #penskemediacorp #sagaftra #michaelflemingjr #africanamerican #nativeamerican #fleming (Source: Reuters: Health)
Source: Reuters: Health - December 9, 2023 Category: Consumer Health News Source Type: news
s Dave Robb Dies: Dean Of Hollywood Labor Reporters Was 74
Longtime Deadline reporter Dave Robb has passed away at age 74. Considered the dean of the Hollywood labor beat, Robb was recently diagnosed with inoperable cancer of the brain stem. This diagnosis came last month. Robb experienced what was initially diagnosed as a small stroke. He and wife Kelly…#daverobb #hollywood #davedeadlines #nra #deadline #hollywoodreporter #variety #laweekly #losangelesdailynews #spy (Source: Reuters: Health)
Source: Reuters: Health - December 9, 2023 Category: Consumer Health News Source Type: news
HER2+ Combo Shows Promise in Breast Cancer Brain Mets HER2+ Combo Shows Promise in Breast Cancer Brain Mets
In previously treated patients with locally advanced unresectable or metastatic HER2-positive breast cancer, tucatinib and trastuzumab emtansine improved progression-free survival vs T-DM1 alone.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 7, 2023 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Peterborough father's brain tumour shock after new baby born
The wife of a man diagnosed with terminal brain cancer says their lives have become a nightmare. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 7, 2023 Category: Consumer Health News Source Type: news
What Pigs and Squirrels Can Teach Us About Managing Pain
Over the past several decades, there have been many supporting studies of the health-promoting effects of an optimistic personality. Much research has been done on the connection between a high level of optimism and good health, described well in clinical psychologists Burel R. Goodin and Hailey W. Bulls’ 2014 research paper, appropriately titled, “Optimism and the Experience of Pain: Benefits of Seeing the Glass as Half Full.” The authors state that optimism “is linked to both enhanced physiological recovery and psychosocial adjustment to coronary artery bypass surgery, bone marrow transplant, post...
Source: TIME: Health - December 4, 2023 Category: Consumer Health News Authors: Dr. David B. Agus Tags: Uncategorized Books freelance Source Type: news
Upstate medical student earns New York Senate commendation for brain cancer advocacy
Nneka Onwumere received the commendation from State Sen. Rachel May. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - November 30, 2023 Category: Universities & Medical Training Tags: News Source Type: news
Malpractice dos and don'ts: Primer scoops top RSNA award
The authors of a practical guide designed to help radiologists avoid malpractice claims have received one of 17 magna cum laude awards handed out by the RSNA 2023 judges. Another prizewinner is about imaging of syphilis.
"The majority of radiologists will face litigation in their careers," noted Luke Michael Wojdyla, a second-year radiology resident, and radiologist James Y. Chen, MD, both of UC San Diego Health in California, adding that in a 2021 survey, 71% of radiologists said they had been sued.
"Despite this, dedicated teaching of medicolegal issues is often lacking or incomplete in radiology training programs. Res...
Source: AuntMinnie.com Headlines - November 29, 2023 Category: Radiology Authors: Philip Ward Tags: MRI RSNA 2023 Source Type: news
Drugs already licensed could be trialled to potentially treat secondary brain cancer, new research finds
The largest review of papers for brain cancer that has spread from the lungs has found abnormalities in the brain cancer and for which licensed drugs could be clinically trialled to find out if they could treat the disease. The research led by the University of Bristol and published in Neuro-Oncology Advances also found genetic differences between smokers and non-smokers. (Source: University of Bristol news)
Source: University of Bristol news - November 29, 2023 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Translational Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news
